IEQ Capital’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
IEQ Capital's PBYI Position: Q3 2026 in Review
IEQ Capital sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 10,671 shares — an estimated $86.5K sold.
IEQ Capital first reported a position in PBYI in Q2 2025 and held it in 4 quarters. The position peaked at $95.2K in Q1 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- IEQ Capital reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
- IEQ Capital sold 10,671 Puma Biotechnology shares in Q3 2026, an estimated $86.5K.
- IEQ Capital first reported a position in Puma Biotechnology in Q2 2025 and held it in 4 quarters.
- IEQ Capital's Puma Biotechnology position peaked at $95.2K in Q1 2026.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.